Table 2.
Outcomes of RH in intraoperative ICG test group and comparison group.
| Variables |
Intraoperative ICG-R15 test group
(n = 20) |
Comparison group
(n = 19) |
P-value |
|---|---|---|---|
| Surgical procedure, n(%) | |||
| RH | 6(30.0%) | 19(100%) | <0.001 |
| Staged procedure | 14(70.0%) | 0 | |
| RH completion, n(%) | |||
| RH | 6(35.3%) | 19(100%) | <0.001 |
| SRH | 11(64.7%) | 0 | |
| Failure for SRH | 3 | ||
| Ishak score | |||
| Fibrosis stage, n (%) | 0.181 | ||
| Stage 1+ stage 2 | 6(35.3%) | 12(63.2%) | |
| Stage 3+ stage 4 | 11(64.7%) | 7(36.8%) | |
| Necroinflammatory grade, n (%) | 0.981 | ||
| Grade 1 | 4(23.5%) | 4(21.0%) | |
| Grade 2 | 8(47.1%) | 9(47.4%) | |
| Grade 3 | 5(29.4%) | 6(31.6%) | |
| PHLF, (n, %) | 0.505 | ||
| None | 10(58.8%) | 8(42.1%) | |
| Grade A+B | 7(41.2%) | 11(67.9%) | |
| Clavien-Dindo, n (%) | 0.281 | ||
| Grade 1 | 10(58.8%) | 15(78.9%) | |
| Grade 2 | 7(41.2%) | 4(21.1%) | |
| Hospital stay after surgery, days | 14(7–47) | 10(6–22) | 0.122 |
| Recurrence within 1 year, n (%) | 6(35.3%) | 7(36.8%) | 1.000 |
| missing | 0 | 1 |
RH, right hepatectomy; SRH, staged right hepatectomy; PHLF, posthepatectomy liver failure.